Strattera

DRUG3 trials

Sponsors

Norwegian University of Science and Technology, University of Oklahoma, Oregon Health and Science University

Conditions

Attention Deficit Disorder (ADD)Attention Deficit Disorder With Hyperactivity (ADHD)Attention Deficit Hyperactivity DisorderFetal Alcohol SyndromeParkinson's Disease

Phase 1

Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD

CompletedNCT00417794

University of OklahomaAttention Deficit Disorder (ADD), Attention Deficit Disorder With Hyperactivity (ADHD), Fetal Alcohol Syndrome

Start: 2005-08-31End: 2015-04-22Updated: 2017-04-10

Phase 4

Cognitive Decline in Non-demented PD

CompletedNCT01340885

Oregon Health and Science UniversityParkinson's Disease

Start: 2011-01-31End: 2013-01-31Updated: 2020-07-07

Unknown Phase

Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison

CompletedNCT00356070

Norwegian University of Science and TechnologyAttention Deficit Hyperactivity Disorder

Start: 2006-01-31End: 2006-12-31Target: 40Updated: 2017-04-28